Veracyte (VCYT) Net Equity Issued and Repurchased (2013 - 2020)

Veracyte (VCYT) posted quarterly Net Equity Issued and Repurchased of $193.8 million for Q3 2020, up 252.17% on a QoQ basis from $55.0 million in Q3 2018.

Veracyte (VCYT) Net Equity Issued and Repurchased (2013 - 2020) Analysis & Trends

Veracyte has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $193.8 million in Q3 2020.

  • Net Equity Issued and Repurchased for Q3 2020 came in at $193.8 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $248.9 million (up 352.17% YoY), and the FY2013 annual result was $12.9 million, down 13.64% from the prior year.
  • Net Equity Issued and Repurchased climbed to $193.8 million in Q3 2020, from $55.0 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $193.8 million in Q3 2020 and troughed at $200000.0 in Q1 2017.
  • A 3-year average of $83.0 million and a median of $55.0 million in 2018 frame the typical range for Net Equity Issued and Repurchased.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn -
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn -
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn -
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Veracyte 3.69 Bn 3.39 Bn 108.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 193.83 Mn
Sep 30, 2020 193.83 Mn
Sep 30, 2018 55.04 Mn
Sep 30, 2018 55.04 Mn
Mar 31, 2017 200,000.00
Mar 31, 2017 200,000.00
Jun 30, 2013 13.00 Mn
Jun 30, 2013 13.00 Mn